Aprio Wealth Management
BIIB icon

Aprio Wealth Management’s Biogen BIIB Stock Holding History

Aprio Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$738K Buy
3,266
+257
+9% +$54.5K 0.03% 321
2026
Q2 		$650K Buy
3,009
+159
+6% +$30.4K 0.03% 324
2026
Q1 		$522K Buy
2,850
+900
+46% +$166K 0.03% 338
2025
Q4 		$343K Buy
+1,950
New +$319K 0.02% 404

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Aprio Wealth Management's BIIB Position: Q3 2026 in Review

Aprio Wealth Management increased its Biogen (BIIB) stake by 8.5% in Q3 2026, buying an estimated $54.5K and bringing the position to 3,266 shares worth $738K. The position accounts for 0.03% of the portfolio, ranked #321.

Aprio Wealth Management first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Aprio Wealth Management held 3,266 shares of Biogen worth $738K as of Q3 2026.
  • Aprio Wealth Management bought 257 Biogen shares in Q3 2026, an estimated $54.5K.
  • Biogen made up 0.03% of Aprio Wealth Management's portfolio in Q3 2026, its #321 holding.
  • Aprio Wealth Management first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Aprio Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.